Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 29.55% is in line with its 5-year average of 31.38%, around the middle of its 5-year range (25.63%–35.86%).
3.31% below its 12-month average of 30.56%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 32.29%.
EBITDA MARGIN
29.55%
EBITDA MARGIN AVG TTM
30.56%
EBITDA MARGIN AVG 3Y
30.69%
EBITDA MARGIN AVG 5Y
31.38%
EBITDA MARGIN AVG 10Y
31.31%
EBITDA MARGIN AVG 15Y
29.27%
EBITDA MARGIN AVG 20Y
27.41%
CURRENT VS TTM AVG
-3.31%
CURRENT VS 3Y AVG
-3.71%
CURRENT VS 5Y AVG
-5.84%
CURRENT VS 10Y AVG
-5.63%
CURRENT VS 15Y AVG
+0.95%
CURRENT VS 20Y AVG
+7.81%
Edwards Lifesciences Corporation
Market Cap
$49.69B
EBITDA Margin
29.55%
TTM Avg
30.56%
3Y Avg
30.69%
5Y Avg
31.38%
Market Cap
$48.80B
EBITDA Margin
25.43%
TTM Avg
26.12%
3Y Avg
26.05%
5Y Avg
25.37%
Market Cap
$50.65B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$45.64B
EBITDA Margin
18.31%
TTM Avg
11.44%
3Y Avg
6.73%
5Y Avg
5.67%
Market Cap
$44.50B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
Market Cap
$40.96B
EBITDA Margin
34.08%
TTM Avg
33.18%
3Y Avg
32.37%
5Y Avg
31.82%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $49.69B | 29.55% | 30.56% | 30.69% | 31.38% |
| Agilent Technologies, Inc. (A)vs › | $48.80B | 25.43% | 26.12% | 26.05% | 25.37% |
| Becton, Dickinson and Company (BDX)vs › | $50.65B | 23.08% | 23.14% | 23.23% | 22.53% |
| Humana Inc. (HUM)vs › | $47.81B | 1.76% | 1.98% | 3.17% | 4.08% |
| Cardinal Health, Inc. (CAH)vs › | $51.58B | 1.40% | 1.39% | 1.08% | 0.86% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $45.64B | 18.31% | 11.44% | 6.73% | 5.67% |
| IQVIA Holdings Inc. (IQV)vs › | $44.50B | 21.04% | 21.29% | 20.90% | 20.09% |
| Waters Corporation (WAT)vs › | $42.57B | 34.73% | 34.58% | 34.05% | 33.84% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.96B | 34.08% | 33.18% | 32.37% | 31.82% |
| Cencora, Inc. (COR)vs › | $59.71B | 1.46% | 1.44% | 1.41% | 1.40% |
Gross Margin
78.0%
EBITDA Margin
29.6%
Operating Margin
28.1%
Net Margin
15.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 32.29% |
| 2026-03-31 | 33.70% |
| 2025-12-31 | 26.31% |
| 2025-09-30 | 29.90% |
| 2025-06-30 | 30.61% |
| 2025-03-31 | 30.54% |
| 2024-12-31 | 25.63% |
| 2024-09-30 | 28.43% |
| 2024-06-30 | 29.17% |
| 2024-03-31 | 29.63% |
| 2023-12-31 | 31.06% |
| 2023-09-30 | 30.83% |
| 2023-06-30 | 31.39% |
| 2023-03-31 | 30.47% |
| 2022-12-31 | 33.49% |
| 2022-09-30 | 35.58% |
| 2022-06-30 | 34.16% |
| 2022-03-31 | 35.60% |
| 2021-12-31 | 30.22% |
| 2021-09-30 | 34.19% |
| 2021-06-30 | 35.86% |
| 2021-03-31 | 35.39% |
| 2020-12-31 | 33.77% |
| 2020-09-30 | 33.66% |
| 2020-06-30 | 27.28% |
| 2020-03-31 | 34.79% |
| 2019-12-31 | 31.31% |
| 2019-09-30 | 28.93% |
| 2019-06-30 | 27.46% |
| 2019-03-31 | 33.02% |
| 2018-12-31 | 31.71% |
| 2018-09-30 | 30.29% |
| 2018-06-30 | 31.94% |
| 2018-03-31 | 31.71% |
| 2017-12-31 | 29.56% |
| 2017-09-30 | 29.06% |
| 2017-06-30 | 32.51% |
| 2017-03-31 | 37.20% |
| 2016-12-31 | 29.70% |
| 2016-09-30 | 29.35% |
| 2016-06-30 | 26.16% |
| 2016-03-31 | 31.23% |
| 2015-12-31 | 28.19% |
| 2015-09-30 | 28.32% |
| 2015-06-30 | 26.52% |
| 2015-03-31 | 30.73% |
| 2014-12-31 | 25.66% |
| 2014-09-30 | 24.28% |
| 2014-06-30 | 23.54% |
| 2014-03-31 | 21.00% |
| 2013-12-31 | 26.16% |
| 2013-09-30 | 24.17% |
| 2013-06-30 | 26.76% |
| 2013-03-31 | 25.13% |
| 2012-12-31 | 28.80% |
| 2012-09-30 | 24.34% |
| 2012-06-30 | 22.78% |
| 2012-03-31 | 21.76% |
| 2011-12-31 | 23.55% |
| 2011-09-30 | 17.88% |
| 2011-06-30 | 20.90% |
| 2011-03-31 | 22.97% |
| 2010-12-31 | 24.46% |
| 2010-09-30 | 23.16% |
| 2010-06-30 | 23.90% |
| 2010-03-31 | 22.53% |
| 2009-12-31 | 22.67% |
| 2009-09-30 | 22.04% |
| 2009-06-30 | 23.07% |
| 2009-03-31 | 21.98% |
| 2008-12-31 | 22.34% |
| 2008-09-30 | 19.14% |
| 2008-06-30 | 20.36% |
| 2008-03-31 | 16.24% |
| 2007-12-31 | 20.17% |
| 2007-09-30 | 19.36% |
| 2007-06-30 | 22.30% |
| 2007-03-31 | 21.96% |
| 2006-12-31 | 21.72% |
| 2006-09-30 | 21.83% |
| 2006-06-30 | 22.48% |
| 2006-03-31 | 31.13% |
| 2005-12-31 | 24.67% |
| 2005-09-30 | 22.46% |
| 2005-06-30 | 23.32% |
| 2005-03-31 | 22.56% |
| 2004-12-31 | 22.94% |
| 2004-09-30 | 22.51% |
| 2004-06-30 | 22.76% |
| 2004-03-31 | 15.45% |
| 2003-12-31 | 22.62% |
| 2003-09-30 | 21.25% |
| 2003-06-30 | 19.47% |
| 2003-03-31 | 20.61% |
| 2002-12-31 | 20.68% |
| 2002-09-30 | -18.58% |
